Molecular Recognition and In-Vitro-Targeted Inhibition of Renal Cell Carcinoma Using a DNA Aptamer

• Päätekijät: Hui Zhang (Tekijä), Zhibo Wang (Tekijä), Lin Xie (Tekijä), Yibin Zhang (Tekijä), Tanggang Deng (Tekijä), Jianglin Li (Tekijä), Jing Liu (Tekijä), Wei Xiong (Tekijä), Lei Zhang (Tekijä), Lin Zhang (Tekijä), Bo Peng (Tekijä), Leye He (Tekijä), Mao Ye (Tekijä), Xiaoxiao Hu (Tekijä), Weihong Tan (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Elsevier, 2018-09-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Renal cell carcinoma (RCC) is the most common malignant tumor of the urinary system, and it has a high frequency of local invasion and distant metastasis. Although multiple advances have been made in the diagnosis and therapy of RCC, the vast majority of patients with metastatic RCC remain incurable...